Open Now
Open Now
Watch now

James Dolan is coronavirus-free and already helping others

Jim Dolan, the 64-year-old CEO of the Garden, has clinically recovered from COVID-19, The Post has learned. An MSG spokesperson confirmed that Dolan, who tested positive the final week of March following exposure to an individual outside the company who carried the coronavirus, recently tested negative and is in good health. Dolan, who had mild …

Jim Dolan, the 64-year-old CEO of the Garden, has clinically recovered from COVID-19, The Post has learned.

An MSG spokesperson confirmed that Dolan, who tested positive the final week of March following exposure to an individual outside the company who carried the coronavirus, recently tested negative and is in good health.

Dolan, who had mild symptoms that included a loss of smell, self-isolated after learning of his positive test but continued to work on a regular schedule from his home.

Having recovered, the owner of the Knicks and Rangers is immersed in the effort to medically combat the virus by volunteering to participate in multiple clinical trials. He has donated blood to NYU Langone Health and Duke University Medical Center.

In addition, Dolan has registered to donate plasma antibodies for a large multicenter through the New York Blood Center and Mt. Sinai. Persons who test negative for COVID-19 after having tested positive must have a high volume of antibodies in order to become a donor.

Dolan qualified.

The Garden has been closed since the Knicks’ overtime victory over the Hawks on March 11. Dolan has created a relief fund for venue employees experiencing hardships related to the virus that opened with a $1 million donation from the CEO, a $1 million donation from the MSG Company and a $300,000 donation from the MSG management team.

In addition, The Post has learned that the Garden sent an internal email on Monday informing qualified employees (based on hours worked) that they will be paid through May 31, extending the commitment past the original date of May 3.

Follow us on Google News